JIM
EBS icon

Jupiter Investment Management’s Emergent Biosolutions EBS Stock Holding History

Jupiter Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,807
Closed -$1.36M – 394
2018
Q1 		$1.36M Buy
+25,807
New +$1.29M 0.01% 256
2016
Q2 		– Sell
-29,257
Closed -$1.06M – 459
2016
Q1 		$1.06M Buy
+29,257
New +$1.03M 0.02% 300

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Jupiter Investment Management's EBS Position: Q2 2018 in Review

Jupiter Investment Management sold out of Emergent Biosolutions (EBS) in Q2 2018, closing a stake of 25,807 shares — an estimated $1.36M sold.

Jupiter Investment Management first reported a position in EBS in Q1 2016 and held it in 2 quarters. The position peaked at $1.36M in Q1 2018. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

  • Jupiter Investment Management reported no remaining Emergent Biosolutions position as of Q2 2018 after selling out during the quarter.
  • Jupiter Investment Management sold 25,807 Emergent Biosolutions shares in Q2 2018, an estimated $1.36M.
  • Jupiter Investment Management first reported a position in Emergent Biosolutions in Q1 2016 and held it in 2 quarters.
  • Jupiter Investment Management's Emergent Biosolutions position peaked at $1.36M in Q1 2018.
  • 263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on Jupiter Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.